Procter & Gamble Hygiene & Health Care Ltd. Stock Hits 52-Week Low at Rs.10,989.8

Recent Price Movement and Market Context

On 4 March 2026, the stock of Procter & Gamble Hygiene & Health Care Ltd. touched Rs.10,989.8, its lowest level in the past year. This new low comes after a three-day consecutive decline, during which the stock has lost approximately 2.24% in returns. Despite this downward trend, the stock outperformed its sector by 1.57% on the day it hit the low, indicating some relative resilience within the FMCG space.

The broader market context saw the Sensex open sharply lower by 1,710.03 points but recover by 272.70 points to trade at 78,801.52, still down 1.79% overall. Notably, other indices such as NIFTY Realty and S&P BSE Realty also recorded new 52-week lows on the same day, reflecting sector-specific pressures in parts of the market.

Procter & Gamble Hygiene & Health Care Ltd. is currently trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This technical positioning underscores the stock’s recent weakness and suggests a cautious market sentiment towards the company’s near-term prospects.

Performance Analysis Over the Past Year

Over the last 12 months, Procter & Gamble Hygiene & Health Care Ltd. has delivered a total return of -16.95%, significantly underperforming the Sensex, which posted a positive return of 7.89% over the same period. This underperformance extends a trend of lagging behind benchmark indices, with the stock also trailing the BSE500 index in each of the past three annual periods.

The stock’s 52-week high was Rs.14,536.6, indicating a substantial decline of nearly 24.4% from that peak to the current 52-week low. This wide price range highlights the volatility and challenges faced by the company’s shares in recent times.

Valuation and Financial Metrics

Procter & Gamble Hygiene & Health Care Ltd. carries a Mojo Score of 43.0 and has recently been downgraded from a Hold to a Sell rating as of 17 October 2024. The company’s market capitalisation grade stands at 2, reflecting its mid-cap status within the FMCG sector.

Despite the stock’s recent price weakness, the company’s financial metrics reveal a complex picture. The return on equity (ROE) is notably high at 92.3%, indicating strong management efficiency in generating profits from shareholder equity. However, this impressive ROE is accompanied by a very expensive valuation, with a price-to-book (P/B) ratio of 38.8, which is considerably above typical sector averages.

The PEG ratio of 2.1 suggests that the stock’s price growth is not fully aligned with its earnings growth, which has been recorded at 20.1% over the past year. Meanwhile, net sales have grown at an annual rate of 5.52% over the last five years, with operating profit increasing at a similar rate of 5.34%, indicating moderate long-term growth.

Operational Highlights and Shareholding

In the quarter ending December 2025, the company reported its highest net sales at Rs.1,261.90 crore and a quarterly PBDIT of Rs.401.80 crore. The operating profit margin to net sales also reached a peak of 31.84%, reflecting operational efficiency during this period.

Procter & Gamble Hygiene & Health Care Ltd. maintains a low average debt-to-equity ratio of zero, signalling a conservative capital structure with minimal reliance on debt financing. The majority shareholding remains with promoters, indicating stable ownership and control.

Comparative Sector and Market Position

Within the FMCG sector, Procter & Gamble Hygiene & Health Care Ltd. has experienced consistent underperformance relative to its peers. The stock’s discount to average historical valuations of comparable companies suggests that the market is pricing in concerns about its growth prospects and valuation premium.

While the company’s high ROE and low leverage are positive attributes, the relatively modest growth rates in net sales and operating profit over the last five years have contributed to a cautious outlook. The stock’s current trading below all major moving averages further reflects subdued momentum in the share price.

Summary of Key Metrics

To summarise, the stock’s key financial and market indicators as of 4 March 2026 are:

• New 52-week low price: Rs.10,989.8
• 1-year return: -16.95%
• Sensex 1-year return: +7.89%
• ROE: 92.3%
• Price to Book Value: 38.8
• PEG Ratio: 2.1
• Net Sales growth (5 years CAGR): 5.52%
• Operating Profit growth (5 years CAGR): 5.34%
• Debt to Equity Ratio: 0 (average)
• Mojo Score: 43.0 (Sell rating)

These figures illustrate the stock’s current valuation challenges and its relative performance within the FMCG sector and broader market indices.

Technical and Market Sentiment Indicators

The stock’s position below all major moving averages signals a lack of upward momentum in the short to medium term. The recent downgrade from Hold to Sell by MarketsMOJO on 17 October 2024 reflects a reassessment of the company’s growth and valuation outlook. The Mojo Grade of Sell and a market cap grade of 2 further underline the cautious stance adopted by market analysts.

Despite the stock’s recent price weakness, the company’s strong management efficiency and conservative capital structure remain notable features. The quarterly results from December 2025, showing record net sales and operating profit margins, indicate that the company continues to deliver operational performance within its core business.

However, the stock’s sustained underperformance relative to the Sensex and BSE500 indices over multiple years highlights the challenges faced in translating operational results into shareholder returns.

Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today